Table of Contents
Preface
Section I: HMGB1 and Cancer
Chapter 1. HMGB1-Targeting Herbal Medicinal Plant Extracts for the Phytotherapy of Cancer and Potential Management of COVID-19
Tuba Reçber¹, PhD, Ibrahim Celalettin Haznedaroglu², MD, and Mustafa Çelebier¹, PhD
¹Hacettepe University, Department of Analytical Chemistry, Ankara Turkey
²Hacettepe University, Department of Hematology, Ankara, Turkey
Chapter 2. The Role of Ferroptotic Cell Death-Related HMGB1 in Inflammation Crosstalk with Cancer and Myocardial Ischemia/Reperfusion Injury
Salih Tunc Kaya¹, PhD, Celal Guven², PhD, and Eylem Taskin³, PhD
¹Düzce University, Department of Biology, Düzce, Turkey
²Adiyaman University, Department of Biophysics, Adiyaman, Turkey
³Adiyaman University, Department of Physiology, Adiyaman, Turkey
Section II: HMGB1 and Metabolic Interactions
Chapter 3. The Role of HMGB1 in Adipocyte Dysfunction Linking Obesity and Type 2 Diabetes
Sagar Barge¹ and Narayan Chandra Talukdar¹,²
¹Chemical Biology Lab I, Institute of Advanced Study in Science and Technology, Paschim Boragaon, Assam, India
²Assam Down Town University, Panikhaiti, Guwahati, India
Chapter 4. The Roles of HMGB1 in Liver Injury
Gülsün Memi
Department of Physiology, Adıyaman University School of Medicine, Adıyaman, Turkey
Section III: HMBG1 and Neurodegenerative Diseases
Chapter 5. The Role of HMGB-1 and Its Inhibitors in Brain Disorders
Onur Cagin Gurlek¹, MD, Anisa Dehghani², PhD, and Hulya Karatas¹, MD, PhD
¹Hacettepe University, Institute of Neurological Sciences and Psychiatry, Ankara, Turkey
²Leiden University Medical Centre, Department of Human Genetics, Migraine Research Group, Leiden, Netherlands
Chapter 6. The Roles of HMGB1 Post-Brain Injury: Implications for Injury and Repair
Malik Zaben¹, PhD, Ron Ved¹,² and Susruta Manivannan²
¹The BRAIN Unit, Neuroscience and Mental Health Research Institute, (NMHRI) School of Medicine, Cardiff University, Cardiff, UK
²Department of Neurosurgery, Southampton General Hospital, Southampton, UK
Chapter 7. The Functional Role of HMGB1/TLR4/NF-κB Signalling Pathway in Multiple Sclerosis
Firdevs Uluc¹, MSc, Bihter Gokce Bozat¹, PhD, Seyda Karabork², PhD and Sule Aydın-Turkoglu³, MD
¹Department of Interdisciplinary Neuroscience, Bolu Abant Izzet Baysal University, Bolu, Turkey
²Department of Medical Microbiology, Bolu Abant Izzet Baysal University, Bolu, Turkey
³Department of Neurology, Bolu Abant Izzet Baysal University, Bolu, Turkey
Chapter 8. HMGB1 Related Pathways in Epilepsy
Hayriye Soyturk¹, PhD, Umit Kilic², PhD, Cansu Onal³, PhD, and Aysegül Yildiz⁴, MSc
¹Bolu Abant Izzet Baysal University, Department of Interdisciplinary Neuroscience, Bolu, Turkey
²Duzce University Vocational School of Health Services, Duzce, Turkey
³Bolu Abant Izzet Baysal University, Department of Biology, Bolu, Turkey
⁴Bolu Abant Izzet Baysal University, Department of Physiology, Bolu, Turkey
About the Editors
Index
Editor’s ORCID iD
Eylem Taskin – 0000-0001-8172-4980
Celal Guven – 0000-0003-0499-7787
Salih Tunc Kaya – 0000-0002-4133-407X